Skip to main content
Recruiting Clinical Trials

Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

By April 24, 2017No Comments

Condition

Mesothelioma

Estimated Enrollment: 386

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Participant, Care Provider, Investigator|Primary Purpose: Treatment

Study ID Numbers: POLARIS2015-003

Study First Received: March 5, 2016

Last Updated: January 25, 2017

Estimated Primary Completion Date: April 2018

 

Primary Outcome Measures:

Response Rate|Progression Free Survival

Sponsors and Collaborators:

Polaris Group

Website Link: https://ClinicalTrials.gov/show/NCT02709512

Leave a Reply